Date Filed | Type | Description |
06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/05/2021 |
4
| DESOUZA ERROL B (Director) has filed a Form 4 on CATALYST BIOSCIENCES, INC.
Txns:
| Granted 3,588 shares
@ $0 |
|
07/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/29/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/28/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/19/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
04/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/23/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/17/2020 |
4
| DESOUZA ERROL B (Director) has filed a Form 4 on Royalty Pharma plc
Txns:
| Granted 35,715 shares
@ $0 |
|
06/15/2020 |
3
| DESOUZA ERROL B (Director) has filed a Form 3 on Royalty Pharma plc |
06/12/2020 |
4
| DESOUZA ERROL B (Director) has filed a Form 4 on CATALYST BIOSCIENCES, INC.
Txns:
| Granted 5,000 options to buy
@ $7.18, valued at
$35.9k
|
|
04/03/2020 |
4
| DESOUZA ERROL B (Director) has filed a Form 4 on CATALYST BIOSCIENCES, INC.
Txns:
| Granted 2,860 shares
@ $0 |
|
01/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/02/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/02/2019 |
4
| DESOUZA ERROL B (Director) has filed a Form 4 on CATALYST BIOSCIENCES, INC.
Txns:
| Granted 1,810 shares
@ $0 |
|
06/17/2019 |
4
| DESOUZA ERROL B (Director) has filed a Form 4 on CATALYST BIOSCIENCES, INC.
Txns:
| Granted 5,000 options to buy
@ $7.46, valued at
$37.3k
|
|
04/02/2019 |
4
| DESOUZA ERROL B (Director) has filed a Form 4 on CATALYST BIOSCIENCES, INC.
Txns:
| Granted 1,504 shares
@ $0 |
|
01/03/2019 |
4
| DESOUZA ERROL B (Director) has filed a Form 4 on CATALYST BIOSCIENCES, INC.
Txns:
| Granted 1,703 shares
@ $0 |
|
06/15/2018 |
4
| DESOUZA ERROL B (Director) has filed a Form 4 on CATALYST BIOSCIENCES, INC.
Txns:
| Granted 5,000 options to buy
@ $24.94, valued at
$124.7k
|
|
02/22/2018 |
4
| DESOUZA ERROL B (Director) has filed a Form 4 on CATALYST BIOSCIENCES, INC.
Txns:
| Disposed of options to buy
@ $0 Disposed of 4,679 options to buy
@ $0 |
|
07/14/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/13/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
12/15/2015 |
4/A
| DESOUZA ERROL B (Director) has filed a Form 4 on CATALYST BIOSCIENCES, INC.
Txns:
| Granted 6,750 options to buy
@ $4.4, valued at
$29.7k
|
|
10/26/2015 |
4
| DESOUZA ERROL B (Director) has filed a Form 4 on CATALYST BIOSCIENCES, INC.
Txns:
| Granted 8,250 options to buy
@ $4.4, valued at
$36.3k
Granted 6,750 options to buy
@ $4.4, valued at
$29.7k
|
|
10/02/2015 |
4
| DESOUZA ERROL B (CEO) has filed a Form 4 on Biodel Inc
Txns:
| Paid exercise price by delivering 43,469 shares
@ $0.44, valued at
$19.1k
Exercised restricted stock units
@ $0 |
|
08/18/2015 |
4
| DESOUZA ERROL B (Director) has filed a Form 4 on TARGACEPT INC
Txns:
| Granted options to buy
@ $1.31, valued at
$0 |
|
12/23/2014 |
4
| DESOUZA ERROL B (CEO) has filed a Form 4 on Biodel Inc
Txns:
| Granted 225,000 options to buy
@ $1.39, valued at
$312.8k
|
|
12/12/2014 |
4
| DESOUZA ERROL B (Director) has filed a Form 4 on TARGACEPT INC
Txns:
| Granted 10,000 shares
@ $0 |
|
11/13/2014 |
4
| DESOUZA ERROL B (CEO) has filed a Form 4 on Biodel Inc
Txns:
| Granted 131,128 restricted stock units
@ $0 |
|
06/13/2014 |
4
| DESOUZA ERROL B (Director) has filed a Form 4 on TARGACEPT INC
Txns:
| Granted 12,500 options to buy
@ $4.29, valued at
$53.6k
|
|
|